{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-033091","form_type":"8-K","ticker":"VBIO","cik":"0001787740","company_name":"Valion Bio, Inc.","filed_at":"2025-03-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.868593+00:00","generated_at":"2026-05-25T10:55:30.187186+00:00","sec_items":["3.03","5.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Tivic Health announces 1-for-17 reverse stock split effective March 7, 2025 to regain Nasdaq compliance","bullets":["Reverse split at 1:17 ratio; effective 12:01 a.m. ET on March 7, 2025.","Purpose: regain Nasdaq $1.00 minimum bid price after delisting notice received December 2024.","Hearing before Nasdaq Panel held Feb 18, 2025; company awaits decision but expects split to aid listing.","No fractional shares; any fractional interest rounded up to nearest whole share.","Trading symbol TIVC unchanged; new CUSIP 888705308."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-033091","json":"https://secwatch.observer/filing/0000950170-25-033091.json","markdown":"https://secwatch.observer/filing/0000950170-25-033091.md","text":"https://secwatch.observer/filing/0000950170-25-033091.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787740/000095017025033091/0000950170-25-033091-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787740/000095017025033091/tivc-20250304.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T10:55:30.187186+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}